Johnson Services

Johnson & Johnson is a global healthcare leader focused on Innovative Medicine (pharmaceuticals) and MedTech (medical devices). Following the 2023 spin-off of its consumer health business, Kenvue, the company has sharpened its focus on high-growth areas such as oncology, immunology, neuroscience, and cardiovascular disease. J&J's pharmaceutical division, formerly known as Janssen, maintains a robust pipeline of biologics and small molecules, including market-leading treatments like Darzalex and Stelara. The company is also a pioneer in advanced modalities such as CAR-T cell therapy and robotic surgery. With a massive global footprint and significant R&D investment, Johnson & Johnson remains one of the most influential entities in the life sciences industry. The company frequently operates through its subsidiary, Johnson & Johnson Services, Inc., for global shared services, innovation initiatives, and strategic partnerships.